Prediction of Non-Response to Anti-Tnf Therapy in Ulcerative Colitis: Implications for Patient Stratification for IBD Trials and Novel Treatment Paradigms

Shannon Telesco(Janssen (United States)), Carrie Brodmerkel(Janssen (United States)), Paul Imm, Ron Mazumder, Katherine Li(Janssen (United States)), Lilianne Kim(Janssen (United States)), Ramineh Zoka, Hongyan Zhang(Lanzhou University), Mark Curran(Janssen (United States)), Jewel Johanns(Johnson & Johnson (United States)), Linda E. Greenbaum(Novartis (United States)), Fred Baribaud, Bethany Paxson(Janssen (United States))

Gastroenterology

April 1, 2017

Cited by 1

|New England Journal of Medicine|2005|3.9k

|New England Journal of Medicine|2016|1.8k

|New England Journal of Medicine|2019|1.2k

|New England Journal of Medicine|2012|1.1k

|Gastroenterology|2013|938

Related Papers